טוען...
Nanoscale artificial antigen presenting cells for cancer immunotherapy
Exciting developments in cancer nanomedicine include the engineering of nanocarriers to deliver drugs locally to tumors, increasing efficacy and reducing off-target toxicity associated with chemotherapies. Despite nanocarrier advances, metastatic cancer remains challenging to treat due to barriers t...
שמור ב:
| הוצא לאור ב: | Mol Immunol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6084459/ https://ncbi.nlm.nih.gov/pubmed/29525074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molimm.2018.02.016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|